English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Survival of patients with sickle cell disease (SCD) in general and sickle cell anemia in particular has increased significantly over the past 40 years. The advent of preventative measures and new therapies has contributed to the increasing longevity of patients with SCD. Recent publications described patients with SCD in their sixth, seventh or eighth decade [1]. As patients with SCD age, they become vulnerable for developing comorbidities that were not previously seen or were rare in this cohort of patients. Thus, the advances in prevention and management may be offset by the increasing incidence of comorbidities associated with aging. This letter focuses on obesity as a comorbidity in SCD. Obesity is a serious epidemic in the USA both in children and adults [2]. Obesity is associated with or a risk factor for other diseases including, but not limited to, type 2 diabetes, hypertension, sleep apnea, cardiovascular disease, osteoarthritis, etc. These diseases, in turn, worsen the clinical picture of SCD and increase the frequency of vaso-occlusive crises (VOCs) and other complications of SCD, thus creating a vicious cycle. Obesity is diagnosed by the determination of the body mass index (BMI) which is calculated by dividing the body weight in kg by the height in meters squared: BMI = kg/m2. The World Health Organization (WHO) classified BMI into five classes as follows: normal (18.5 24.9), overweight (25.0 29.9), obese class I (30.0 34.9), obese class II (35.0 39.9), and obese class III (> 40.0). Survival was reported to be directly related to the BMI [3]. The prevalence of obesity in patients with SCD seems to be on the increase [4]. We have compared the BMI of some of our patients when first seen in the steady state and five or more years later as shown in Table 1. There was a surprisingly significant increase in the BMI especially in women with hemoglobin SCD. Accordingly we recommend that the BMI should be routinely determined as a sixth vital sign in addition to temperature, respiratory rate, heart rate, blood pressure, and pain scale in all patients with SCD. The best approach to manage obesity in patients with SCD is to follow the recommendations of the US Preventive Task Force (USPSTF) [5]. Providers should screen all adult patients for obesity and refer patients with BMI > 30 to multicomponent interventions. Dietary management entails the determination of the daily calorie requirement for each patient best determined by a nutritionist. Bariatric surgery may be considered if dietary management fails.

The Sixth Vital Sign: Body Mass Index in Patients With Sickle Cell Disease